QSM Asset Management Buys $6.8 Million of Pfizer Stock as Pharma Giant Lags Market

On Thursday, QSM Asset Management disclosed a significant buy of Pfizer (NYSE:PFE), adding shares worth an estimated $6.8 million in the third quarter.QSM Asset Management increased its position in Pfizer, adding 276,899 shares in the third quarter of 2025, according to a filing with the Securities and Exchange Commission released on Thursday. The estimated value of the purchase, based on the period’s average share price, was approximately $6.8 million for the quarter ended September 30. This brought the firm’s total Pfizer holdings to 460,743 shares, worth $11.3 million.QSM’s Pfizer position now represents 8.1% of the fund’s 13F assets under management.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool